Q: Thoughts please on the Pangeo acquisition and the bought deal at .50 per share. Tough hit for existing shareholders in the short term, would you be a buyer of these shares today at .50 or less?
Q: You found some microcaps interesting years ago and I'm wondering if you still like some of them and/or perhaps there are others you like for a 5-10 year hold?
Q: A big move up for Kraken this week on what I thought was a fairly minor announcement. Your thoughts on why the stock popped so much on big volume and would you be a buyer of this stock at $1 for a 2-3 year hold?
Thanks for the great service.
Rob
Q: I’m wondering what you think of PNG ( Kraken Robotics). They recently announced some deals for their equipment with a few Countries, what kind of prospects do you see for them and would you see them as an acquisition target by a larger Defence company ?
Thanks
Q: PNG recently did a $10M "bought deal" financing at $.67. If it is a "bought deal" does that mean Canaccord are in essence buying $10M worth of newly issued shares at $.67 and they are getting a big discount (prior market was $.78-.80)? Will Canaccord be re-selling these shares to clients at a premium to themselves or just adding them to their own portfolios? Also, if Cannacord have already bought the shares why is the market reacting so negatively? Is it because of the dilution? Last but not least why such a big discount for Canaccord?
Q: Hi Team, thoughts on Krakens announcements of today. They seem to be on a roll and h as very just hit $100 million market cap.
Do you recommend at this new level?
Thanks
Rob
Q: Kraken - Current earnings appear to show modest revenue despite a significant contract announcement some while ago, so I am wondering about the growth prospects for this company. What I would like to ask is whether the market for Kraken's products provide a good opportunity for growth or is it inherently small/limited in prospects?
Greenlane appears to be struggling to break even notwithstanding improving revenue, a (significantly?) larger backlog and what I would call an outstanding quote book which borders on the gigantic. How do you view the prospects for GRN as well as XBC, assuming they don't get Trumped like Questor?
Re DOC and WELL I have been trying to determine whether these two have the same/similar business models or not, as the more recent announcements by DOC have been on the acquisition of clinics to support a team, which appears to be a collaborative model for medical services, while WELL's emphasis appears to be on digital records and remote services. Do these two occupy the same space or are they inherently different and might one offer better prospects than the other?
Thank you for your responses.
Q: I am always interested in penny stocks with actual earnings that seem overlooked by the market. Are you aware of any reasons why this stock is so continually overlooked or, conversely, any upcoming activity that might burst the stock out of its sub-$.25 status?
Q: Can you provide some analysis on Kraken robotics with the recent announcement of 40 Million orders which is nearly 2X of their current annual revenue. Is the price supposed to increase 2X as well?
Q: Hi 5i - appreciate your thoughts on Kraken Robotics given recent insider buying and decent Q1 results. Worth a small entry position at this point as part of a small cap growth portfolio? Thanks
Q: I have what I call a mini portfolio of higher risk stocks in addition to my portfolio of diversified quality portfolio.
I presently hold ATE, AKU, PNG. I want to add 3 oil stocks to this portfolio. Thinking maybe, VET, MEG and NVA. Opinion. Any other likely candidates in the smal/mid cap. Candidates should be less than $5 and a good hedge position to protect them over the next 6 months.